UC - ULCERATIVE COLITIS
Clinical trials for UC - ULCERATIVE COLITIS explained in plain language.
Never miss a new study
Get alerted when new UC - ULCERATIVE COLITIS trials appear
Sign up with your email to follow new studies for UC - ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug LYNC-101 enters first human trials for ulcerative colitis
Disease control Not yet recruitingThis early-stage trial tests the safety of an experimental drug called LYNC-101 in 50 healthy adults. The drug is given by IV infusion, either as a single dose or multiple doses every 3 weeks. The goal is to see if it is safe and how the body processes it, before testing it in pe…
Matched conditions: UC - ULCERATIVE COLITIS
Phase: PHASE1 • Sponsor: LyncBio Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New oral drug could replace steroids for severe colitis Flare-Ups
Disease control Not yet recruitingThis study tests whether the oral medication upadacitinib can safely treat acute severe ulcerative colitis in hospitalized adults without using steroids. Fifty participants will take upadacitinib daily during their hospital stay and be monitored for up to a year. The goal is to s…
Matched conditions: UC - ULCERATIVE COLITIS
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC